Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
Battistella M, Beylot-Barry M, Bachelez H, Rivet J, Vergier B, Bagot M. Battistella M, et al. Among authors: Vergier B. Arch Dermatol. 2012 Jul;148(7):832-9. doi: 10.1001/archdermatol.2011.3269. Arch Dermatol. 2012. PMID: 22508770
Such lymphomas are characterized by a nodal neoplastic T-cell proliferation accompanied by numerous reactive B cells and demonstrate some overlap with nodal angioimmunoblastic T-cell lymphoma (AITL). ...In 3 cases, findings from skin biopsy specimens were initially misdiagnosed as primary cutaneous follicle B-cell lymphoma due to major B-cell infiltrate and CD10 positivity. ...
Such lymphomas are characterized by a nodal neoplastic T-cell proliferation accompanied by numerous reactive B cells and demonstrate …
Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F, Maubec E, Bagot M, Beylot-Barry M, Joly P, Dalle S, Delaporte E, Dereure O, Bachelez H, Vergier B, Petrella T, D'Incan M. Grange F, et al. Among authors: Vergier B. Arch Dermatol. 2009 Mar;145(3):329-30. doi: 10.1001/archdermatol.2009.23. Arch Dermatol. 2009. PMID: 19289772 No abstract available.
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T. Grange F, et al. Among authors: Vergier B. Arch Dermatol. 2007 Sep;143(9):1144-50. doi: 10.1001/archderm.143.9.1144. Arch Dermatol. 2007. PMID: 17875875 Clinical Trial.
MAIN OUTCOME MEASURES: Age, sex, outcome, therapy, B symptoms, cutaneous extent, number of lesions, location (leg vs nonleg), serum lactate dehydrogenase level, and MUM-1 and Bcl-2 expression were recorded. ...CONCLUSIONS: Primary cutaneous diffuse large B-cell lymphoma, leg type is a distinct entity with a poor prognosis, particularly in patients with multiple tumors on the legs. ...
MAIN OUTCOME MEASURES: Age, sex, outcome, therapy, B symptoms, cutaneous extent, number of lesions, location (leg vs nonleg), serum l …
MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.
Menguy S, Gros A, Pham-Ledard A, Battistella M, Ortonne N, Comoz F, Balme B, Szablewski V, Lamant L, Carlotti A, Lorton MH, de Muret A, Le Gall F, Franck F, Croue A, Cappellen D, Beylot-Barry M, Merlio JP, Vergier B. Menguy S, et al. Among authors: Vergier B. J Invest Dermatol. 2016 Aug;136(8):1741-1744. doi: 10.1016/j.jid.2016.04.018. Epub 2016 May 14. J Invest Dermatol. 2016. PMID: 27189828 No abstract available.
PLCG1 Gene Mutations Are Uncommon in Cutaneous T-Cell Lymphomas.
Caumont C, Gros A, Boucher C, Mélard P, Prochazkova-Carlotti M, Laharanne E, Pham-Ledard A, Vergier B, Chevret E, Beylot-Barry M, Merlio JP, Cappellen D. Caumont C, et al. Among authors: Vergier B. J Invest Dermatol. 2015 Sep;135(9):2334-2337. doi: 10.1038/jid.2015.161. Epub 2015 Apr 24. J Invest Dermatol. 2015. PMID: 25910029 No abstract available.
Bone involvement in two cases of thoracic primary cutaneous diffuse large B-cell lymphoma, leg type.
Lipowicz S, Beylot-Barry M, Choquet S, Maksud P, Vergier B, Albertini AF, Frances C, Barete S. Lipowicz S, et al. Among authors: Vergier B. Eur J Dermatol. 2011 Sep-Oct;21(5):744-9. doi: 10.1684/ejd.2011.1431. Eur J Dermatol. 2011. PMID: 21700538
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT), is defined by a predominance of confluent sheets of centroblasts and immunoblasts, which strongly express Bcl-2 protein. ...PCLBCL-LT is distinguished from the two other subtypes of primary cutaneous B-cell lymphomas by its immunohistopathological features, its aggressive clinical behaviour with a worse prognosis linked to skin recurrences, but also secondary extracutaneous spread. ...
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT), is defined by a predominance of confluent sheets of centroblas …
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
Grange F, Joly P, Barbe C, Bagot M, Dalle S, Ingen-Housz-Oro S, Maubec E, D'Incan M, Ram-Wolff C, Dalac S, Templier I, Esteve E, Quereux G, Machet L, Leduc M, Dereure O, Laroche L, Saiag P, Vergier B, Beylot-Barry M. Grange F, et al. Among authors: Vergier B. JAMA Dermatol. 2014 May;150(5):535-41. doi: 10.1001/jamadermatol.2013.7452. JAMA Dermatol. 2014. PMID: 24647650 Clinical Trial.
IMPORTANCE: Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), occurs in elderly patients and has been considered as a lymphoma with a poor prognosis, with estimated 5-year specific survival rates of approximately 50%. ...
IMPORTANCE: Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), occurs in elderly patients and has been considere …
195 results
Jump to page
Feedback